Bulut Gökten, D. and Mercan, R. 2026. Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye. Rheumatology (Bulgaria). 34, 1 (May 2026), 4–20. DOI:https://doi.org/10.35465/wx09tq86.